tiprankstipranks
Cel-Sci Corp. Secures Funding for Multikine Development
Company Announcements

Cel-Sci Corp. Secures Funding for Multikine Development

Cel-Sci Corp. (CVM) has released an update.

Don't Miss Our Christmas Offers:

CEL-SCI Corporation has successfully completed an offering of 3,875,000 common stock shares at $2.00 each, raising $7.75 million before expenses. This capital will primarily fund the development of their Multikine product, as well as for general corporate purposes and working capital. The offering, which closed on February 13, 2024, was facilitated by ThinkEquity LLC, acting as the representative for the underwriters. The shares were sold under a previously effective registration statement and were subject to standard underwriting terms, including indemnification obligations and termination provisions.

For further insights into CVM stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyCEL-SCI provides rationale for use of Multikine in head, neck cancer study
TheFlyCEL-SCI, FDA agree on patient selection approach for Multikine study
TheFlyCEL-SCI files to sell 1M shares of common stock for holders
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App